Liquid biopsy in germ cell tumors: biology and clinical management

Michal Chovanec, Katarina Kalavska, Michal Mego, Liang Cheng

Research output: Contribution to journalReview article

Abstract

Introduction: Liquid biopsy is an increasingly studied approach for optimal and minimally invasive diagnostics of malignant tumors. The aim of this review is to provide evidence and discuss the utility of liquid biopsy in the management of germ cell tumors (GCTs). Areas covered: Herein, we summarize the evidence on liquid biopsy in GCTs including serum tumor markers, circulating tumor cells, microRNA and cell-free DNA. The search of literature was conducted from Pubmed/Medline, ASCO-meeting library searching for terms ‘liquid biopsy’, ‘germ cell tumors’, ‘circulating tumor cells’, ‘microRNA’, ‘cell-free DNA’. Obtained original studies were included. Reference lists of review articles and key original articles were searched for additional original studies. We included articles published between1990 and 2019. Expert opinion: Liquid biopsy is a minimally invasive tool using body fluids for diagnostic purposes in cancer. The established value of serum tumor markers may be already considered a liquid biopsy technique in diagnosis of GCTs. Possible near-future refinements in diagnosis of GCTs are emerging. Further information on diagnosis, prognosis and resistance is added with recently described microRNAs, circulating tumor cells and cell-free DNA. While great promise is shown, further large-scale validation is needed to incorporate these novel liquid biopsies into clinical practice.

Original languageEnglish (US)
JournalExpert Review of Molecular Diagnostics
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Germ Cell and Embryonal Neoplasms
Cell Biology
Biopsy
Circulating Neoplastic Cells
MicroRNAs
Tumor Biomarkers
DNA
Biomarkers
Expert Testimony
Body Fluids
PubMed
Libraries
Neoplasms

Keywords

  • biomarker
  • cell-free DNA
  • circulating tumor cells
  • germ cell tumors
  • Liquid biopsy
  • microRNA
  • testicular cancer

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Liquid biopsy in germ cell tumors : biology and clinical management. / Chovanec, Michal; Kalavska, Katarina; Mego, Michal; Cheng, Liang.

In: Expert Review of Molecular Diagnostics, 01.01.2019.

Research output: Contribution to journalReview article

@article{336a93c278fc42c090bd4b71e2b53a04,
title = "Liquid biopsy in germ cell tumors: biology and clinical management",
abstract = "Introduction: Liquid biopsy is an increasingly studied approach for optimal and minimally invasive diagnostics of malignant tumors. The aim of this review is to provide evidence and discuss the utility of liquid biopsy in the management of germ cell tumors (GCTs). Areas covered: Herein, we summarize the evidence on liquid biopsy in GCTs including serum tumor markers, circulating tumor cells, microRNA and cell-free DNA. The search of literature was conducted from Pubmed/Medline, ASCO-meeting library searching for terms ‘liquid biopsy’, ‘germ cell tumors’, ‘circulating tumor cells’, ‘microRNA’, ‘cell-free DNA’. Obtained original studies were included. Reference lists of review articles and key original articles were searched for additional original studies. We included articles published between1990 and 2019. Expert opinion: Liquid biopsy is a minimally invasive tool using body fluids for diagnostic purposes in cancer. The established value of serum tumor markers may be already considered a liquid biopsy technique in diagnosis of GCTs. Possible near-future refinements in diagnosis of GCTs are emerging. Further information on diagnosis, prognosis and resistance is added with recently described microRNAs, circulating tumor cells and cell-free DNA. While great promise is shown, further large-scale validation is needed to incorporate these novel liquid biopsies into clinical practice.",
keywords = "biomarker, cell-free DNA, circulating tumor cells, germ cell tumors, Liquid biopsy, microRNA, testicular cancer",
author = "Michal Chovanec and Katarina Kalavska and Michal Mego and Liang Cheng",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/14737159.2019.1685383",
language = "English (US)",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",

}

TY - JOUR

T1 - Liquid biopsy in germ cell tumors

T2 - biology and clinical management

AU - Chovanec, Michal

AU - Kalavska, Katarina

AU - Mego, Michal

AU - Cheng, Liang

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Liquid biopsy is an increasingly studied approach for optimal and minimally invasive diagnostics of malignant tumors. The aim of this review is to provide evidence and discuss the utility of liquid biopsy in the management of germ cell tumors (GCTs). Areas covered: Herein, we summarize the evidence on liquid biopsy in GCTs including serum tumor markers, circulating tumor cells, microRNA and cell-free DNA. The search of literature was conducted from Pubmed/Medline, ASCO-meeting library searching for terms ‘liquid biopsy’, ‘germ cell tumors’, ‘circulating tumor cells’, ‘microRNA’, ‘cell-free DNA’. Obtained original studies were included. Reference lists of review articles and key original articles were searched for additional original studies. We included articles published between1990 and 2019. Expert opinion: Liquid biopsy is a minimally invasive tool using body fluids for diagnostic purposes in cancer. The established value of serum tumor markers may be already considered a liquid biopsy technique in diagnosis of GCTs. Possible near-future refinements in diagnosis of GCTs are emerging. Further information on diagnosis, prognosis and resistance is added with recently described microRNAs, circulating tumor cells and cell-free DNA. While great promise is shown, further large-scale validation is needed to incorporate these novel liquid biopsies into clinical practice.

AB - Introduction: Liquid biopsy is an increasingly studied approach for optimal and minimally invasive diagnostics of malignant tumors. The aim of this review is to provide evidence and discuss the utility of liquid biopsy in the management of germ cell tumors (GCTs). Areas covered: Herein, we summarize the evidence on liquid biopsy in GCTs including serum tumor markers, circulating tumor cells, microRNA and cell-free DNA. The search of literature was conducted from Pubmed/Medline, ASCO-meeting library searching for terms ‘liquid biopsy’, ‘germ cell tumors’, ‘circulating tumor cells’, ‘microRNA’, ‘cell-free DNA’. Obtained original studies were included. Reference lists of review articles and key original articles were searched for additional original studies. We included articles published between1990 and 2019. Expert opinion: Liquid biopsy is a minimally invasive tool using body fluids for diagnostic purposes in cancer. The established value of serum tumor markers may be already considered a liquid biopsy technique in diagnosis of GCTs. Possible near-future refinements in diagnosis of GCTs are emerging. Further information on diagnosis, prognosis and resistance is added with recently described microRNAs, circulating tumor cells and cell-free DNA. While great promise is shown, further large-scale validation is needed to incorporate these novel liquid biopsies into clinical practice.

KW - biomarker

KW - cell-free DNA

KW - circulating tumor cells

KW - germ cell tumors

KW - Liquid biopsy

KW - microRNA

KW - testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=85074902978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074902978&partnerID=8YFLogxK

U2 - 10.1080/14737159.2019.1685383

DO - 10.1080/14737159.2019.1685383

M3 - Review article

C2 - 31652083

AN - SCOPUS:85074902978

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

ER -